EUCTR2006-004084-66-IT进行中（未招募）不适用
A phase II study on the efficacy and safety of topotecan in the treatment of patients with brain metastases - ND
OSPEDALE ONCOLOGICO DI BARI0 个研究点开始时间: 2007年6月18日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Unresectable brain metastases
- •2. Patients with chemosensitive neoplasms must have received chemoterapic for advanced desease
- •3. Asymptomatic brain metastases
- •4. Age>18 and <75 years
- •5. Life expectancy of 12 weeks at least
- •6. Normal kidney and liver parameters
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Histologically proved brain glioma
- •2. Contemporary radiotherapy
- •3. Immunotherapy
- •4. Pregnancy or breast-feeding
研究者
相似试验
已完成
3 期
A pilot study comparing efficacy and safety of topical 3% minoxidil solution with topical 3% minoxidil solution combined with topical 0.25% finasteride solution in treatment of female pattern hair loss.Androgenetic alopeciaFemale pattern hair lossTCTR20160912002Division of Dermatology, Ramathibodi Hospital, Mahidol University30
进行中（未招募）
不适用
A study to find out whether treating patients who have liver metastases from eye melanoma with radiofrequency ablation combined with ipilimumab, will kill the tumor without them having too many adverse events.EUCTR2011-004200-38-NLKI-AV
招募中
3 期
Diphencyprone and anthralin in alopecia areataAlopecia areataIRCT20141209020250N4Tehran University of Medical Sciences40
尚未招募
2 期
A clinical study on the effect of external application of drug murivenna oil in external piles for pain reduction.CTRI/2024/07/070486DR SAI SHASHANK K
招募中
3 期
Study of Out of Specification for TisagenlecleucelPediatric/young adult patients with r/r pALL and adult patients with r/r LBCL (including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma) for Part 1, and r/r ALL and r/r NHL for Part 2.JPRN-jRCT1080224903ovartis Pharma. K.K.200